Overview
News
Salaries
Products
People
Growth
Offices
Financials

News

Press release Nasdaq 7 years ago
Histogenics Corporation Announces Intent to Convene and Adjourn Its Special Meeting
--Histogenics Corporation today announced that it intends to convene and then adjourn, without conducting any business, its special meeting of stockholders to be held with respect to its proposed merger with Ocugen, Inc. pursuant to the Agreement and Plan
Read more
Report
News YahooFinance 8 years ago
What is Next for Histogenics, Pending FDA Meeting and Analysts Target Price
NEW YORK, NY / ACCESSWIRE / October 24, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Histogenics Corporation (HSGX) is a clin
Read more
Report
News YahooFinance 8 years ago
Histogenics Slips Below $1 Threshold After Knee Cartilage Candidate Fails Late-Stage Study
Histogenics Corp (NASDAQ: HSGX) shares were losing more than half their market value Wednesday following the release of top-line data from the Phase 3 trial of Neocart, its pipeline candidate to treat knee cartilage damage. Histogenics, a developer of res
Read more
Report
News 24/7 Wall St. 12 years ago
Histogenics Files for IPO
Histogenics Corp. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
Read more
Report
News CNBC 14 years ago
Histogenics Honored as a 2012
WALTHAM, Mass.---- Histogenics, a regenerative medicine company combining cell therapy and tissue engineering technologies to develop highly innovative products for tissue repair and regeneration, announced today that it has been named to the FierceMedica
Read more
Report

People

Adam Gridley
Executive Officer, Director
Sanjay Subramanian
Executive Officer
Shankar Musunuri
Executive Officer, Director
Daniel Jorgensen
Executive Officer
Kelly Beck
Executive Officer
Rasappa Arumugham
Executive Officer
Vijay Tammara
Executive Officer
John Johnson
Director
Joshua Baltzell
Director
Kevin Rakin
Director
David Gill
Director
Jonathan Lieber
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Waltham United States
HQ
50-200 est. staff

Financials

Total raised
$93.3M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2020 $14.3M Details
Venture - Series Unknown 2020 $395 Details
Venture - Series Unknown 2016 $30M Details
Series A 2012 $49M Details